Mechanistic studies demonstrated that LBX2-AS1 acted as ceRNA to sponge miR-422a to increase AKT1 expression resulting in the enhanced resistance of CRC cells to 5-FU administration. Here, AKT1 is linked to colorectal carcinoma.